Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShoe Zone Regulatory News (SHOE)

Share Price Information for Shoe Zone (SHOE)

Share Price is delayed by 15 minutes
Get Live Data
57.50    0.00 (0.00%)
Bid:
55.00
Ask:
60.00
Spread: 5.00 (9.091%)
Market Cap: £26.58m
SHOE Live PriceLast checked at - London Stock Exchange

Intraday Shoe Zone Share Chart

Share Buyback Programme

30 Mar 2023 07:00

RNS Number : 6967U
Shoe Zone PLC
30 March 2023
 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 to the extent it forms part of the domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018 (as amended by virtue of the European Union (Withdrawal Agreement) Act 2020). Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Shoe Zone plc

("Shoe Zone" or the "Company")

Share Buyback Programme

Shoe Zone announces that it intends to conduct a share buyback programme of ordinary shares of £0.01 each in the capital of the Company ("Ordinary Shares") up to a maximum aggregate consideration of £3,000,000 ("Maximum Amount") (the "Buyback Programme").

The Company entered into an irrevocable and non-discretionary arrangement with its broker, Zeus Capital Limited ("Zeus"), on 29 March 2023 to enable Zeus to conduct the Buyback Programme on its behalf on a broker-managed basis, with trading decisions being taken independently of the Company albeit subject to certain limitations (including in respect of the maximum price payable per Ordinary Share).

The Buyback Programme commences today and ends on 30 June 2023 or, if earlier, the date upon which the aggregate consideration paid for Ordinary Shares reaches the Maximum Amount (the "Buyback Period"). During the Buyback Period the Company has no power to invoke any changes to the authority and any purchases will be undertaken by Zeus, acting independently of, and uninfluenced by, the Company.

The Buyback Programme is in accordance with the terms of the Company's authority to make market purchases of its own Ordinary Shares granted to it by shareholders on 9 March 2023 (the "Authority"), including that the maximum price paid per Ordinary Share shall not exceed the higher of: (a) 105 per cent. of the average trading price of the Ordinary Shares as derived from the middle market quotations for an Ordinary Share on the London Stock Exchange Daily Official List for the five trading days immediately preceding the date on which an Ordinary Share is contracted to be purchased; and (b) the higher of the price of the last independent trade and the highest current independent bid on the trading venue where the purchase is carried out.

Any Ordinary Shares acquired as a result of the Buyback Programme will be initially held in treasury and then cancelled periodically.

Due to the limited liquidity in the issued Ordinary Shares, the purchase by the Company of Ordinary Shares pursuant to the Authority on any trading day is likely to represent a significant proportion of the daily trading volume in the Ordinary Shares on AIM and is likely to exceed 25 per cent. of the average daily trading volume, being the limit laid down in Article 5(1) of Regulation (EU) No 596/2014 (to the extent it forms part of the domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018 (as amended by virtue of the European Union (Withdrawal Agreement) Act 2020)) and, accordingly, the Company will not benefit from the exemption contained in such Article.

No Ordinary Shares will be sold by any member of the Board or their connected parties (including, in particular, by or on behalf of Slawston Investments Limited ("SIL") or Sheepy Magna Investments Limited ("SMIL"), being companies connected with Anthony Smith and Charles Smith respectively) as part of the Buyback Programme.

SIL and SMIL, in aggregate, are interested in over 50 per cent. of the total issued Ordinary Shares (with SIL being interested in 30.8 per cent. and SMIL being interested in 24.6 per cent. of the total issued Ordinary Shares (excluding Ordinary Shares held in treasury) as at the date of this announcement). However, as announced on 29 July 2022, the Panel has previously confirmed that, pursuant to Note 1 of Rule 37.1 of the Takeover Code, SIL did not, and neither SIL nor SMIL will, incur an obligation to make a mandatory offer pursuant to Rule 9 of the Takeover Code should either of their respective interests in the Company exceed 30 per cent. of the total issued Ordinary Shares or increase above 30 per cent. of the total issued Ordinary Shares (as applicable), in each case as a result of any share purchases conducted through a share buyback programme.

The Company will make further announcements in due course following any share purchases conducted through the Buyback Programme.

The Company confirms that it currently has no unpublished price sensitive information.

 For further information please call:

Shoe Zone PLC Tel: +44 (0) 116 222 3000

Anthony Smith (Chief Executive)

Terry Boot (Finance Director)

 

Zeus (Nominated Adviser and Broker) Tel: +44 (0) 203 829 5000

David Foreman, James Hornigold, Ed Beddows (Investment Banking)

Dominic King (Corporate Broking)

 

About Shoe Zone

Shoe Zone is a Town Centre, Retail Park and Digital footwear retailer, offering low price and high quality footwear for the whole family.

Shoe Zone operates from a portfolio of 336 stores and has approximately 2,480 employees across the UK.

The store portfolio consists of 227 original high street stores containing the core Shoe Zone product range and 65 hybrid high street stores and 44 Big Box, larger retail park stores which also have additional brands such as Skechers, Hush Puppies and Kickers.

Shoezone.com, combined with the store network, ensures a full multi-channel offering for great customer service.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSDBGDXXBDDGXC
Date   Source Headline
20th May 20262:47 pmRNSHolding(s) in Company
20th May 20267:00 amRNSDirector & PDMR Dealing
11th May 20267:00 amRNSInterim Results
22nd Apr 20267:00 amRNSTrading Update
10th Mar 202612:07 pmRNSResult of Annual General Meeting
10th Mar 202612:07 pmRNSResult of Annual General Meeting
2nd Feb 202611:04 amRNSPosting of Annual Report and Notice of AGM
13th Jan 20267:00 amRNSFinal Results
23rd Oct 20257:00 amRNSFull Year Trading Update
13th Aug 20257:00 amRNSTrading Update
21st May 20257:00 amRNSInterim Results
11th Mar 202512:31 pmRNSResult of Annual General Meeting
18th Feb 20257:00 amRNSPosting of Annual Report and Notice of AGM
21st Jan 20257:00 amRNSFinal Results
18th Dec 20247:00 amRNSTrading Update
22nd Oct 20247:00 amRNSFull Year Trading Update
3rd Jul 20247:00 amRNSDirectors' Dealing
2nd Jul 20247:00 amRNSTrading Update
27th Jun 20245:06 pmRNSNotice of cyber security incident
21st May 20247:00 amRNSInterim Results
13th May 20245:28 pmRNSHolding(s) in Company
16th Apr 20247:00 amRNSDirectorate Change
26th Mar 20243:37 pmRNSHolding(s) in Company
12th Mar 202411:51 amRNSResult of Annual General Meeting
12th Mar 202410:00 amRNSAGM Statement
31st Jan 20247:00 amRNSPosting of Annual Report, AGM & Dividend Timetable
9th Jan 20247:00 amRNSFinal Results
17th Oct 20237:00 amRNSFull Year Trading Update
12th Jul 20237:00 amRNSTrading Update
9th Jun 20237:00 amRNSTrading Update
7th Jun 202310:26 amRNSHolding(s) in Company
6th Jun 20237:01 amRNSShare Buyback and Cancellation of Shares
6th Jun 20237:00 amRNSTransaction in Own Shares
5th Jun 20231:43 pmRNSHolding(s) in Company
5th Jun 202310:28 amRNSHolding(s) in Company
1st Jun 20237:01 amRNSHolding(s) in Company
1st Jun 20237:00 amRNSTransaction in Own Shares
31st May 20237:00 amRNSShare Buyback Programme
23rd May 20231:17 pmRNSHolding(s) in Company
18th May 20237:00 amRNSShare Buyback and Cancellation of Shares
17th May 20237:00 amRNSTransaction in Own Shares
16th May 20237:00 amRNSTransaction in Own Shares
16th May 20237:00 amRNSInterim Results
15th May 20237:00 amRNSTransaction in Own Shares
12th May 20233:45 pmRNSHolding(s) in Company
12th May 20237:01 amRNSHolding(s) in Company
12th May 20237:00 amRNSTransaction in Own Shares
11th May 202312:44 pmRNSCancellation of Ordinary Shares
4th May 202310:47 amRNSHolding(s) in Company
4th May 20237:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.